SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharma - Quaterly Results

04 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 696.50 millions grew by 24.46 % from Rs. 559.63 millions.Profit after Tax for the quarter ended September 2023 saw a decline of -30.84% from Rs. 90.48 millions to Rs. 62.58  millions.The company reported a degrowth in operating Profit to 154.99 millions from 163.26 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 696.50 559.63 24.46 1371.00 1261.82 8.65 2509.95 4561.32 -44.97
Other Income 2.34 7.52 -68.88 6.30 11.29 -44.20 29.41 35.12 -16.26
PBIDT 154.99 163.26 -5.07 297.03 347.26 -14.46 632.29 1752.37 -63.92
Interest 24.11 11.83 103.80 45.96 24.02 91.34 60.20 29.17 106.38
PBDT 130.88 151.43 -13.57 251.07 323.24 -22.33 406.80 1723.20 -76.39
Depreciation 48.77 38.27 27.44 96.56 69.58 38.78 149.19 106.44 40.16
PBT 82.11 113.16 -27.44 154.51 253.66 -39.09 257.61 1616.76 -84.07
TAX 19.53 22.68 -13.89 37.47 57.68 -35.04 62.92 416.28 -84.89
Deferred Tax -1.96 -3.09 -36.57 -2.25 -3.09 -27.18 1.37 2.75 -50.18
PAT 62.58 90.48 -30.84 117.04 195.98 -40.28 194.69 1200.48 -83.78
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.25 29.17 -23.72 21.67 27.52 -21.28 25.19 38.42 -34.43

Kwality Pharma Share Price

1664.30 -82.70 (-4.73%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×